Short Bowel Syndrome Market Projected to Grow Rapidly from 2024 to 2031 - OxThera Inc, VectivBio AG & Nutrinia.

Short Bowel Syndrome Market is estimated to reach at a CAGR of 15.9% during the forecast period (2024-2031).

DataM Intelligence has published a new research report on "Short Bowel Syndrome Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/short-bowel-syndrome-market

Short Bowel Syndrome (SBS) is a medical condition characterized by inadequate nutrient absorption due to the surgical removal or congenital absence of a significant portion of the small intestine. This syndrome can lead to malabsorption of nutrients, fluids, and electrolytes, resulting in diarrhea, weight loss, and nutritional deficiencies. SBS often occurs after surgical procedures for conditions such as Crohn's disease, trauma, or intestinal malrotation.

Key Developments:

In December 2020, 9 Meters Biopharma, Inc. announced positive topline results from its open-label Phase 1b/2a clinical trial of NM-002, a proprietary long-acting glucagon-like peptide-1 (GLP-1) receptor agonist intended for adults with Short Bowel Syndrome (SBS). NM-002 is designed as a long-acting injectable formulation that leverages proprietary XTEN technology to extend its circulating half-life. This innovative treatment aims to slow digestive transit time in SBS patients by reducing upper gastrointestinal motility, ultimately helping to alleviate chronic diarrhea associated with a shortened intestine.

Research Process:

Both primary and secondary data sources have been used in the global Short Bowel Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

List of the Key Players in the Short Bowel Syndrome Market:

Takeda Pharmaceutical Company Limited, OxThera Inc, VectivBio AG, Nutrinia, Merck KGaA, Pfizer Inc, Ardelyx, Zealand Pharma, and Nestlé S.A.

Segment Covered in the Short Bowel Syndrome Market:

By Drug Class: GLP-2, Growth Hormone, Glutamine, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others.

Regional Analysis:

The global Short Bowel Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/short-bowel-syndrome-market

Regional Analysis:

The global Short Bowel Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Short Bowel Syndrome Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Short Bowel Syndrome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Short Bowel Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/short-bowel-syndrome-market

Frequently Asked Questions

Q1) How Big is the Short Bowel Syndrome Market?

A) Short Bowel Syndrome Market is estimated to reach at a CAGR of 15.9% during the forecast period (2024-2031).

Q2) Who are the key players of Short Bowel Syndrome Market?

A) Takeda Pharmaceutical Company Limited, OxThera Inc, VectivBio AG, Nutrinia, Merck KGaA, Pfizer Inc, Ardelyx, Zealand Pharma, and Nestlé S.A.

Q3) What are the regions covered in this report?

A) The global Short Bowel Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa

4) What are the Segments Coverd in this report?

A) The Short Bowel Syndrome market is segmented as By Drug Class, By Distribution Channel, and By Region.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.